28. April 2010 / by Michael Lutz / 2010
Constance, Germany – LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics. LifeCodexx will utilize GATC Biotech’s 20 years of experience as well as its sequencing laboratory, which is the European leader with a total capacity of more than 2 terabases per year.
Read more
GATC subsidiary LifeCodexx AG develops tests for prenatal diagnostics
28. April 2010 / by Michael Lutz / 2010
Constance, Germany – LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics. LifeCodexx will utilize GATC Biotech’s 20 years of experience as well as its sequencing laboratory, which is the European leader with a total capacity of more than 2 terabases per year.
Read more